Author
Listed:
- Moritz Lassé
(University Medical Center Hamburg-Eppendorf (UKE)
University Medical Center Hamburg-Eppendorf)
- Jamal El Saghir
(University of Michigan Medical School)
- Celine C. Berthier
(University of Michigan Medical School)
- Sean Eddy
(University of Michigan Medical School)
- Matthew Fischer
(University of Michigan Medical School)
- Sandra D. Laufer
(University Medical Center Hamburg-Eppendorf (UKE)
University Medical Center Hamburg-Eppendorf)
- Dominik Kylies
(University Medical Center Hamburg-Eppendorf (UKE)
University Medical Center Hamburg-Eppendorf)
- Arvid Hutzfeldt
(University Medical Center Hamburg-Eppendorf (UKE)
University Medical Center Hamburg-Eppendorf)
- Léna Lydie Bonin
(Aarhus University)
- Bernhard Dumoulin
(University Medical Center Hamburg-Eppendorf (UKE)
University Medical Center Hamburg-Eppendorf)
- Rajasree Menon
(University of Michigan Medical School)
- Virginia Vega-Warner
(University of Michigan Medical School)
- Felix Eichinger
(University of Michigan Medical School)
- Fadhl Alakwaa
(University of Michigan Medical School)
- Damian Fermin
(University of Michigan Medical School)
- Anja M. Billing
(Aarhus University)
- Akihiro Minakawa
(University of Michigan Medical School)
- Phillip J. McCown
(University of Michigan Medical School)
- Michael P. Rose
(University of Michigan Medical School)
- Bradley Godfrey
(University of Michigan Medical School)
- Elisabeth Meister
(University Medical Center Hamburg-Eppendorf (UKE)
University Medical Center Hamburg-Eppendorf)
- Thorsten Wiech
(University Medical Center Hamburg-Eppendorf
University Medical Center Hamburg-Eppendorf (UKE))
- Mercedes Noriega
(University Medical Center Hamburg-Eppendorf
University Medical Center Hamburg-Eppendorf (UKE))
- Maria Chrysopoulou
(Aarhus University)
- Paul Brandts
(University Medical Center Hamburg-Eppendorf (UKE)
University Medical Center Hamburg-Eppendorf)
- Wenjun Ju
(University of Michigan Medical School)
- Linda Reinhard
(University Medical Center Hamburg-Eppendorf (UKE)
University Medical Center Hamburg-Eppendorf)
- Elion Hoxha
(University Medical Center Hamburg-Eppendorf (UKE)
University Medical Center Hamburg-Eppendorf)
- Florian Grahammer
(University Medical Center Hamburg-Eppendorf (UKE)
University Medical Center Hamburg-Eppendorf)
- Maja T. Lindenmeyer
(University Medical Center Hamburg-Eppendorf (UKE)
University Medical Center Hamburg-Eppendorf)
- Tobias B. Huber
(University Medical Center Hamburg-Eppendorf (UKE)
University Medical Center Hamburg-Eppendorf)
- Hartmut Schlüter
(University Medical Center Hamburg-Eppendorf (UKE))
- Steffen Thiel
(Aarhus University)
- Laura H. Mariani
(University of Michigan Medical School)
- Victor G. Puelles
(University Medical Center Hamburg-Eppendorf (UKE)
University Medical Center Hamburg-Eppendorf
Aarhus University
Aarhus University Hospital)
- Fabian Braun
(University Medical Center Hamburg-Eppendorf (UKE)
University Medical Center Hamburg-Eppendorf)
- Matthias Kretzler
(University of Michigan Medical School
University of Michigan Medical School)
- Fatih Demir
(Aarhus University)
- Jennifer L. Harder
(University of Michigan Medical School)
- Markus M. Rinschen
(University Medical Center Hamburg-Eppendorf (UKE)
University Medical Center Hamburg-Eppendorf
Aarhus University
Aarhus Institute of Advanced Studies (AIAS))
Abstract
Kidney organoids are a promising model to study kidney disease, but their use is constrained by limited knowledge of their functional protein expression profile. Here, we define the organoid proteome and transcriptome trajectories over culture duration and upon exposure to TNFα, a cytokine stressor. Older organoids increase deposition of extracellular matrix but decrease expression of glomerular proteins. Single cell transcriptome integration reveals that most proteome changes localize to podocytes, tubular and stromal cells. TNFα treatment of organoids results in 322 differentially expressed proteins, including cytokines and complement components. Transcript expression of these 322 proteins is significantly higher in individuals with poorer clinical outcomes in proteinuric kidney disease. Key TNFα-associated protein (C3 and VCAM1) expression is increased in both human tubular and organoid kidney cell populations, highlighting the potential for organoids to advance biomarker development. By integrating kidney organoid omic layers, incorporating a disease-relevant cytokine stressor and comparing with human data, we provide crucial evidence for the functional relevance of the kidney organoid model to human kidney disease.
Suggested Citation
Moritz Lassé & Jamal El Saghir & Celine C. Berthier & Sean Eddy & Matthew Fischer & Sandra D. Laufer & Dominik Kylies & Arvid Hutzfeldt & Léna Lydie Bonin & Bernhard Dumoulin & Rajasree Menon & Virgin, 2023.
"An integrated organoid omics map extends modeling potential of kidney disease,"
Nature Communications, Nature, vol. 14(1), pages 1-21, December.
Handle:
RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-39740-7
DOI: 10.1038/s41467-023-39740-7
Download full text from publisher
References listed on IDEAS
- Lorna J. Hale & Sara E. Howden & Belinda Phipson & Andrew Lonsdale & Pei X. Er & Irene Ghobrial & Salman Hosawi & Sean Wilson & Kynan T. Lawlor & Shahnaz Khan & Alicia Oshlack & Catherine Quinlan & Ra, 2018.
"3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening,"
Nature Communications, Nature, vol. 9(1), pages 1-17, December.
- Benjamin S. Freedman & Craig R. Brooks & Albert Q. Lam & Hongxia Fu & Ryuji Morizane & Vishesh Agrawal & Abdelaziz F. Saad & Michelle K. Li & Michael R. Hughes & Ryan Vander Werff & Derek T. Peters & , 2015.
"Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids,"
Nature Communications, Nature, vol. 6(1), pages 1-13, December.
- Ayshwarya Subramanian & Eriene-Heidi Sidhom & Maheswarareddy Emani & Katherine Vernon & Nareh Sahakian & Yiming Zhou & Maria Kost-Alimova & Michal Slyper & Julia Waldman & Danielle Dionne & Lan T. Ngu, 2019.
"Single cell census of human kidney organoids shows reproducibility and diminished off-target cells after transplantation,"
Nature Communications, Nature, vol. 10(1), pages 1-15, December.
- Camilla Calandrini & Frans Schutgens & Rurika Oka & Thanasis Margaritis & Tito Candelli & Luka Mathijsen & Carola Ammerlaan & Ravian L. Ineveld & Sepide Derakhshan & Sanne Haan & Emmy Dolman & Philip , 2020.
"An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity,"
Nature Communications, Nature, vol. 11(1), pages 1-14, December.
Full references (including those not matched with items on IDEAS)
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.
- Jessica M. Vanslambrouck & Sean B. Wilson & Ker Sin Tan & Ella Groenewegen & Rajeev Rudraraju & Jessica Neil & Kynan T. Lawlor & Sophia Mah & Michelle Scurr & Sara E. Howden & Kanta Subbarao & Melissa, 2022.
"Enhanced metanephric specification to functional proximal tubule enables toxicity screening and infectious disease modelling in kidney organoids,"
Nature Communications, Nature, vol. 13(1), pages 1-23, December.
- J. O. R. Hernandez & X. Wang & M. Vazquez-Segoviano & M. Lopez-Marfil & M. F. Sobral-Reyes & A. Moran-Horowich & M. Sundberg & D. O. Lopez-Cantu & C. K. Probst & G. U. Ruiz-Esparza & K. Giannikou & R., 2021.
"A tissue-bioengineering strategy for modeling rare human kidney diseases in vivo,"
Nature Communications, Nature, vol. 12(1), pages 1-16, December.
- Ning Qing Liu & Irene Paassen & Lars Custers & Peter Zeller & Hans Teunissen & Dilara Ayyildiz & Jiayou He & Juliane Laura Buhl & Eelco Wieger Hoving & Alexander Oudenaarden & Elzo Wit & Jarno Drost, 2023.
"SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors,"
Nature Communications, Nature, vol. 14(1), pages 1-14, December.
- Sienna R. Li & Ramila E. Gulieva & Louisa Helms & Nelly M. Cruz & Thomas Vincent & Hongxia Fu & Jonathan Himmelfarb & Benjamin S. Freedman, 2022.
"Glucose absorption drives cystogenesis in a human organoid-on-chip model of polycystic kidney disease,"
Nature Communications, Nature, vol. 13(1), pages 1-12, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-39740-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.